Newron Pharmaceuticals S.p.A. announced the appointment of Ulrich Köstlin as non-executive director and Chairman, Robert Leslie Holland as non-executive director, and Bo Jesper Hansen as non-executive director.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.36 CHF | +3.60% | +6.69% | +109.29% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+109.29% | 206M | |
-1.85% | 89.87B | |
-3.95% | 37.57B | |
-10.97% | 32.75B | |
+63.31% | 26.47B | |
-20.35% | 14.25B | |
-6.39% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+6.14% | 9.11B |
- Stock Market
- Equities
- NWRN Stock
- News Newron Pharmaceuticals S.p.A.
- Newron Pharmaceuticals S.p.A. Announces Board Appointments